Array
(
    [REDIRECT_SCRIPT_URL] => /dxpgx/underwriters-exercise-option-bg-medicine-ipo
    [REDIRECT_SCRIPT_URI] => http://www.genomeweb.com/dxpgx/underwriters-exercise-option-bg-medicine-ipo
    [REDIRECT_STATUS] => 200
    [SCRIPT_URL] => /dxpgx/underwriters-exercise-option-bg-medicine-ipo
    [SCRIPT_URI] => http://www.genomeweb.com/dxpgx/underwriters-exercise-option-bg-medicine-ipo
    [HTTP_HOST] => www.genomeweb.com
    [HTTP_USER_AGENT] => CCBot/2.0
    [HTTP_ACCEPT_LANGUAGE] => en-us,en-gb,en;q=0.7,*;q=0.3
    [HTTP_ACCEPT] => text/html,application/xhtml+xml,application/xml;q=0.9,*/*;q=0.8
    [HTTP_ACCEPT_ENCODING] => gzip
    [HTTP_X_FORWARDED_FOR] => 23.22.76.170, 23.22.76.170
    [HTTP_X_VARNISH] => 1568987418
    [PATH] => /sbin:/usr/sbin:/bin:/usr/bin
    [SERVER_SIGNATURE] => 
Apache/2.2.3 (CentOS) Server at www.genomeweb.com Port 80
[SERVER_SOFTWARE] => Apache/2.2.3 (CentOS) [SERVER_NAME] => www.genomeweb.com [SERVER_ADDR] => 127.0.0.1 [SERVER_PORT] => 80 [REMOTE_ADDR] => 23.22.76.170 [DOCUMENT_ROOT] => /var/www/genomeweb.com/htdocs [SERVER_ADMIN] => root@localhost [SCRIPT_FILENAME] => /var/www/genomeweb.com/htdocs/index.php [REMOTE_PORT] => 37842 [REDIRECT_QUERY_STRING] => q=dxpgx/underwriters-exercise-option-bg-medicine-ipo [REDIRECT_URL] => /dxpgx/underwriters-exercise-option-bg-medicine-ipo [GATEWAY_INTERFACE] => CGI/1.1 [SERVER_PROTOCOL] => HTTP/1.1 [REQUEST_METHOD] => GET [QUERY_STRING] => q=dxpgx/underwriters-exercise-option-bg-medicine-ipo [REQUEST_URI] => /dxpgx/underwriters-exercise-option-bg-medicine-ipo [SCRIPT_NAME] => /index.php [PHP_SELF] => /index.php [REQUEST_TIME] => 1369314964 ) Underwriters Exercise Option on BG Medicine IPO | GenomeWeb Daily News | Clinical Genomics | GenomeWeb

Underwriters Exercise Option on BG Medicine IPO

Following the exercise of the over-allotment option, BG's net proceeds from the IPO were roughly $35 million.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories